These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 15269153)

  • 21. Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):94-102. PubMed ID: 18771702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
    Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor.
    Slice LW; Hodikian R; Zhukova E
    J Cell Physiol; 2003 Sep; 196(3):454-63. PubMed ID: 12891702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
    Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
    Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
    Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats.
    Komori M; Tsuji S; Sun WH; Tsujii M; Kawai N; Yasumaru M; Kakiuchi Y; Kimura A; Sasaki Y; Higashiyama S; Kawano S; Hori M
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1368-78. PubMed ID: 12388195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
    Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin 1alpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol.
    Morisset S; Patry C; Lora M; de Brum-Fernandes AJ
    J Rheumatol; 1998 Jun; 25(6):1146-53. PubMed ID: 9632078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
    Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
    Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors.
    Konturek PC; Nikiforuk A; Kania J; Raithel M; Hahn EG; Mühldorfer S
    Dig Dis Sci; 2004 Aug; 49(7-8):1075-83. PubMed ID: 15387324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms.
    Subramaniam D; Ramalingam S; May R; Dieckgraefe BK; Berg DE; Pothoulakis C; Houchen CW; Wang TC; Anant S
    Gastroenterology; 2008 Apr; 134(4):1070-82. PubMed ID: 18395088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.